Evidence map›Paper›PMID 41664021›Full record

ArticleBMC medical imaging2026

Ultrasound-based attention-guided deep learning combined with radiomics to predict axillary lymph node metastasis in breast cancer.

Heng Zhang, Tong Zhao, Sai Zhang, Zi-Yi Wang, Nan-Nan Cao, Jiang-Yi Ding, Xiao-Qin Li, Xiao-Li Zhou, Xin-Ye Ni

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heng ZhangDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China.
Tong ZhaoDepartment of Ultrasound, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213164, China.
Sai ZhangDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China.
Zi-Yi WangDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China.
Nan-Nan CaoDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China.
Jiang-Yi DingDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China.
Xiao-Qin LiDepartment of Ultrasound, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213164, China.
Xiao-Li ZhouDepartment of Pathology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213000, China.
Xin-Ye NiDepartment of Radiotherapy Oncology, Changzhou No.2 People's Hospital, Nanjing Medical University, Changzhou, 213003, China. nxy@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe accurate preoperative identification of axillary lymph node (ALN) metastasis status is important for treatment decision-making and prognostic assessment for patients with breast cancer. The aim of this study was to develop a multiscale feature fusion model (CBAM_DenseNet201_RC), which integrates attention-guided deep learning from ultrasound, radiomics, and clinical features for the preoperative prediction of ALN status in patients with breast cancer.

methodsRetrospectively, 323 eligible breast cancer patients in our hospital between January 2018 and December 2021 were analyzed and included, and randomly divided into a training group (226 patients) and test group (97 patients) according to a 7:3 ratio. First, the initial prediction of the DenseNet201 baseline deep learning model was applied on the pre-processed completed ultrasound images of the training and test groups, and the Convolutional Block Attention Module (CBAM), which sequentially applies both spatial and channel weighting, was integrated to obtain the attention-enhanced deep learning features. Then, the radiomics features of the preprocessed ultrasound were extracted separately, and the Mann-Whitney U-test, random forest recursive feature elimination, least absolute shrinkage and selection operator three-step methods were utilized to reduce the dimensionality of the features and construct the radiomics signatures. Single/multifactor analysis was used to screen valuable clinical features. Finally, the attention-enhanced deep learning features, radiomics signatures and valuable clinical features were sequentially input into a logistic regression classifier to construct a multi-scale feature fusion model.

resultsOn the test group, the AUC of DenseNet201 was 0.771 (95% CI: 0.675–0.856). the AUC of the CBAM-guided DenseNet201 model (CBAM_DenseNet201) could be further improved to 0.795 (0.692–0.878). In contrast, CBAM_DenseNet201_RC achieved the best predictive performance with an AUC as high as 0.834 (0.741–0.906), which outperformed all the sub-models, with an AUC of 0.797 (0.701–0.880) for the radiomics model and an AUC of 0.707 (0.589–0.809) for the clinical model.

conclusionsA multiscale feature fusion model constructed by ultrasound-based attention-guided deep learning in conjunction with radiomics can effectively, noninvasively, and accurately predict ALN metastasis, enabling radiologists to formulate early diagnosis and treatment plans and potentially improving the survival rate for patients with breast cancer.

Indexed as

Breast NeoplasmsDeep LearningLymphatic MetastasisLymph NodesUltrasonography, MammaryAxillaFemaleHumansMiddle AgedRadiomicsRetrospective StudiesUltrasonographyAttention mechanismAxillary lymph node metastasisBreast cancerDeep learningRadiomicsUltrasound

Identifiers

PMID41664021
PMCPMC12983787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.